Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

被引：0
|
作者：
Sangjin Shin
Chan Mi Park
Hanbyeol Kwon
Kyung-Hun Lee
机构：
[1] National Evidence-based healthcare Collaborating Agency,Department of Internal Medicine
[2] Seoul National University Hospital,Cancer Research Institute
[3] Seoul National University College of Medicine,undefined
来源：
BMC Cancer | / 16卷
关键词：
Pancreatic cancer; Gemcitabine; Erlotinib; Comparative effectiveness research; National database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
    Shin, Sangjin
    Park, Chan Mi
    Kwon, Hanbyeol
    Lee, Kyung-Hun
    BMC CANCER, 2016, 16
  • [2] EROLTINIB PLUS GEMCITABINE COMPA RED WITH GEMCITABINE MONOTHERAPY IN PATIENTS WITH PANCREATIC CANCER: A REAL-WORLD ANA LYSIS OF KOREAN NATIONA-WIDE DATABASE
    Shin, S.
    Park, C.
    Kwon, H.
    Suh, J.
    Cho, S.
    Shin, M.
    VALUE IN HEALTH, 2015, 18 (07) : A435 - A435
  • [3] Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
    Kang, Sora
    Yoo, Changhoon
    Lee, So Heun
    Oh, Dongwook
    Song, Tae Jun
    Lee, Sang Soo
    Jeong, Jae Ho
    Park, Do Hyun
    Seo, Dong Wan
    Park, Jin-hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Kwak, Bong Jun
    Hong, Sarang
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Kim, Kyu-pyo
    Kim, Song Cheol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [4] Cost-effectiveness of nab-paclitaxel plus gemcitabine versus erlotinib plus gemcitabine in metastatic pancreatic cancer
    Chiorean, E. Gabriela
    Whiting, Scott
    Binder, Gary
    Dranitsaris, George
    Manax, Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [5] Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
    Maraveyas, A.
    Waters, J.
    Roy, R.
    Fyfe, D.
    Propper, D.
    Lofts, F.
    Sgouros, J.
    Gardiner, E.
    Wedgwood, K.
    Ettelaie, C.
    Bozas, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (09) : 1283 - 1292
  • [6] Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
    Rimini, Margherita
    Masi, Gianluca
    Lonardi, Sara
    Pressiani, Tiziana
    Lavacchi, Daniele
    Nichetti, Federico
    Jessica, Lucchetti
    Giordano, Guido
    Scartozzi, Mario
    Tamburini, Emiliano
    Pastorino, Alessandro
    Rapposelli, Ilario Giovanni
    Daniele, Bruno
    Martinelli, Erika
    Garajova, Ingrid
    Aprile, Giuseppe
    Schirripa, Marta
    Formica, Vincenzo
    Salani, Francesca
    Winchler, Costanza
    Bergamo, Francesca
    Balsano, Rita
    Gusmaroli, Eleonora
    Lorenzo, Angotti
    Landriscina, Matteo
    Pretta, Andrea
    Toma, Ilaria
    Pirrone, Chiara
    Diana, Anna
    Leone, Francesco
    Brunetti, Oronzo
    Brandi, Giovanni
    Garattini, Silvio Ken
    Satolli, Maria Antonietta
    Rossari, Federico
    Fornaro, Lorenzo
    Niger, Monica
    Zanuso, Valentina
    De Rosa, Antonio
    Ratti, Francesca
    Aldrighetti, Luca
    De Braud, Filippo
    Foti, Silvia
    Rizzato, Mario Domenico
    Vivaldi, Caterina
    Stefano, Cascinu
    Rimassa, Lorenza
    Antonuzzo, Lorenzo
    Casadei-Gardini, Andrea
    TARGETED ONCOLOGY, 2024, 19 (3) : 359 - 370
  • [7] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Wang, Ying
    Camateros, Pierre
    Cheung, Winson Y.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 62 - 68
  • [8] Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
    de Jong, Evelien J. M.
    Janssen, Quisette P.
    Simons, Tessa F. A.
    Besselink, Marc G.
    Bonsing, Bert A.
    Bouwense, Stefan A. W.
    Geurts, Sandra M. E.
    Homs, Marjolein Y., V
    de Meijer, Vincent E.
    Tjan-Heijnen, Vivianne C. G.
    van Laarhoven, Hanneke W. M.
    Valkenburg-van Iersel, Liselot B. J.
    Wilmink, Johanna W.
    van der Geest, Lydia G.
    Koerkamp, Bas Groot
    de Vos-Geelen, Judith
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (10) : 1654 - 1663
  • [9] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Ying Wang
    Pierre Camateros
    Winson Y. Cheung
    Journal of Gastrointestinal Cancer, 2019, 50 : 62 - 68
  • [10] Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis
    Guoqing Ouyang
    Zhipeng Liu
    Shengfu Huang
    Qianglong Li
    Li Xiong
    Xiongying Miao
    Yu Wen
    World Journal of Surgical Oncology, 14
12345